Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CareDx

CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential

CareDx, Inc. (NASDAQ:CDNA) faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions platform positions it for long-term opportunity in an $8 billion market.

CareDx Shows Market Leadership With Jump To 92 RS Rating

CareDx Shows Market Leadership With Jump To 92 RS Rating

CareDx sees its Relative Strength Rating move into the elite 90-plus level.

Investors Business Daily

CareDx Joins Elite Club Of Stocks With RS Ratings Over 90

CareDx Joins Elite Club Of Stocks With RS Ratings Over 90

CareDx shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

CareDx Clears Key Benchmark, Hitting 80-Plus RS Rating

CareDx sees its Relative Strength Rating move into the 80-plus level.

Investors Business Daily

Stocks To Watch: CareDx Sees RS Rating Jump To 84

CareDx sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30

Reuters Taiwan’s China Airlines Orders 16 Boeing 787s

CareDx's Return On Capital Employed Overview

CareDx (NASDAQ:CDNA) brought in sales totaling $79.42 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 21.65%, resulting in a loss of $19.65 million.

inkl

Read news from The Economist, FT, and more,
with one subscription

CareDx: Q1 Earnings Insights

CareDx: Q1 Earnings Insights

CareDx (NASDAQ:CDNA) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings CareDx missed estimated earnings by 160.0%, reporting an EPS of $-0.13 versus an estimate of $-0.05.

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

Recap: CareDx Q4 Earnings

Recap: CareDx Q4 Earnings

CareDx (NASDAQ:CDNA) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings CareDx missed estimated earnings by 200.0%, reporting an EPS of $-0.03 versus an estimate of $0.03.

People

Vitalik Buterin

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Investor Business Daily

Wall Street Journal

Advanced Micro Devices

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

302,804 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play